Altamira Therapeutics Ltd. (CYTO) Earning

NASDAQ Currency in USD Disclaimer

$0.30

south_east -$0 (0%)
Day's range
$0.3
Day's range
$0.42

Altamira Therapeutics Ltd. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$2.22 -$2.22 -$2.22
Q2 2024 1 -$545.29 -$545.29 -$545.29
Q3 2024 1 -$433.95 -$433.95 -$433.95
Q1 2025 1 -$433.95 -$433.95 -$433.95
Q2 2025 1 -$372.90 -$372.90 -$372.90
Q1 2026 1 -$0.48 -$0.48 -$0.48
Q2 2026 1 -$0.43 -$0.43 -$0.43
Q3 2026 1 -$2.02 -$2.02 -$2.02
Q4 2026 1 -$0.49 -$0.49 -$0.49
Q1 2027 1 -$0.44 -$0.44 -$0.44
Q2 2027 1 -$0.46 -$0.46 -$0.46

Altamira Therapeutics Ltd. Earnings Date And Information

Altamira Therapeutics Ltd. last posted its earnings results on Tuesday, September 24th, 2024. The company reported $-1.98517 earnings per share for the quarter, topping analysts' consensus estimates of $-2.38032 by $0.39515. The company had revenue of 52,735 for the quarter and had revenue of 0 for the year. Altamira Therapeutics Ltd. has generated $-15 earnings per share over the last year ($-14.8 diluted earnings per share) and currently has a price-to-earnings ratio of -0.02. Altamira Therapeutics Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 24th, 2024 based on prior year's report dates.

Altamira Therapeutics Ltd. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
06/28/2023 Q2 2023 -$12.91 $52,735
03/30/2023 Q1 2023 -$12.97 $52,735
05/16/2023 Q4 2022 -$2.89 $0
09/29/2022 Q3 2022 -$199.86 $-458,691
11/30/2022 Q2 2022 -$106.32 $145,399
11/30/2022 Q1 2022 -$106.32 $145,399
04/12/2022 Q4 2021 $164.89 $0
09/29/2021 Q3 2021 -$149.92 $0
03/31/2021 Q2 2021 -$438.94 -$108.47 330.47 $0
03/31/2021 Q1 2021 -$438.94 -$108.47 330.47 $0
03/31/2021 Q4 2020 -$438.94 -$148.91 290.03 $237,000
09/29/2020 Q3 2020 -$510.79 -$148.91 361.88 $0
09/17/2020 Q2 2020 -$115.96 $0
09/17/2020 Q1 2020 -$115.96 $0
04/16/2020 Q4 2019 -$32.00 -$83.44 -51.44 $-56,000
09/29/2019 Q3 2019 $0.00 $0
06/30/2019 Q2 2019 -$165.85 $0
03/30/2019 Q1 2019 $0.00 $0
03/14/2019 Q4 2018 -$485.21 $1.27 M
09/30/2018 Q3 2018 -$569.22 $0
 

Altamira Therapeutics Ltd. Earnings: FAQ's

When is Altamira Therapeutics Ltd.'s earnings date?

Altamira Therapeutics Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, September 24th, 2024 based off last year's report dates.

Did Altamira Therapeutics Ltd. beat their earnings estimates last quarter?

In the previous quarter, Altamira Therapeutics Ltd. (:CYTO) reported $-1.98517 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.38032 by $0.39515.

How can I listen to Altamira Therapeutics Ltd.'s earnings conference call?

The conference call for Altamira Therapeutics Ltd.'s latest earnings report can be listened to online.

How can I read Altamira Therapeutics Ltd.'s conference call transcript?

The conference call transcript for Altamira Therapeutics Ltd.'s latest earnings report can be read online.

How much profit does Altamira Therapeutics Ltd. generate each year?

Altamira Therapeutics Ltd. (:CYTO) has a recorded net income of $0. Altamira Therapeutics Ltd. has generated $-14.81 earnings per share over the last four quarters.

What is Altamira Therapeutics Ltd.'s price-to-earnings ratio?

Altamira Therapeutics Ltd. (:CYTO) has a price-to-earnings ratio of -0.02 and price/earnings-to-growth ratio is -0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED